Le marché des dispositifs et équipements de traitement de l'infertilité était évalué à 1 050,00 millions de dollars américains en 2019 et devrait atteindre 1 973,68 millions de dollars américains d'ici 2027 ; il devrait croître à un TCAC de 8,4 % de 2020 à 2027.
Comme divers facteurs contribuent au faible taux de fécondité de la population, le nombre de patients cherchant un traitement contre l'infertilité augmente. Il existe de nombreuses options de traitement de l'infertilité disponibles pour les patients. De nombreux facteurs contribuent au faible taux de fertilité, donc dans les années à venir, le nombre de patients cherchant un traitement contre l'infertilité va augmenter. De nombreuses entreprises ont développé de nouveaux dispositifs et procédures pour un traitement de la fertilité simple, efficace et rentable.
La portée du marché des dispositifs et équipements de traitement de l'infertilité comprend le type de produit, la procédure, l'utilisateur final et la région. L'analyse régionale du marché est basée sur l'Amérique du Nord, l'Europe, l'Asie-Pacifique, le Moyen-Orient et l'Afrique, ainsi que l'Amérique du Sud et centrale. Le rapport offre des informations et une analyse approfondie du marché des dispositifs et équipements de traitement de l'infertilité, en mettant l'accent sur divers paramètres tels que les tendances du marché, les avancées technologiques, la dynamique du marché et l'analyse du paysage concurrentiel des principaux acteurs du marché mondial.
Régions lucratives pour le marché des dispositifs et équipements de traitement de l'infertilité
Aperçu du marché
Incidence croissante de l'infertilité chez les deux sexes
Selon la définition clinique de l'Organisation mondiale de la santé, l'infertilité est l'incapacité d'un individu à réaliser une grossesse clinique saine. Cependant, l'infertilité peut toucher les deux sexes, hommes et femmes, mais la plupart des recherches sur ce sujet se concentrent uniquement sur les femmes. Les taux de fécondité mesurent le pourcentage moyen d'enfants par femme. Le taux de fécondité est en baisse constante dans le monde, en raison de divers facteurs tels que la tendance croissante des mariages tardifs et l'augmentation de l'infertilité liée à l'âge. Les taux de fécondité mondiaux devraient chuter à 2,4 enfants par femme d'ici 2030 et à 2,2 enfants par femme d'ici 2050. de l'état matrimonial. De plus, environ 6,0 % des femmes mariées âgées de 15 à 44 ans aux États-Unis sont incapables de tomber enceintes après un an d'essai (infertilité). Selon le National Center for Health Statistics, le taux de natalité aux États-Unis en 2018 était estimé à 11 968 naissances pour 1 000 personnes, soit une baisse de 0,95 % par rapport à 2017. De plus, les maladies à chlamydia causent environ 4 à 5 millions d'infections par an aux États-Unis. S'il n'est pas traité à temps, il peut entraîner l'infertilité chez les hommes et les femmes.
En outre, selon un rapport sur la fécondité mondiale 2019, des estimations des taux de natalité chez les adolescentes sont disponibles pour 2015-2020 pour 201 pays ou régions d'au moins 90 000 habitants. Des déclins rapides de la fécondité ont été observés dans toutes les grandes régions. Parmi les soixante-dix-sept pays et zones où la fécondité des adolescentes a diminué de plus de 50 % entre 1990-1995 et 2015-2020, 28 se trouvaient en Europe, 28 en Asie, 8 en Afrique (Algérie, Botswana et autres), 7 dans Caraïbes (Bahamas, Porto Rico, Grenade, Aruba, Martinique, Sainte-Lucie et les îles Vierges américaines), 4 en Océanie (Guam, Kiribati, Micronésie et Nouvelle-Calédonie), et au Canada et aux États-Unis. Ainsi, la baisse du taux de fécondité entraîne une augmentation significative de la demande de dispositifs et d'équipements de traitement de l'infertilité qui déterminent la fenêtre de fertilité chez les hommes et les femmes.
Dispositifs et équipements de traitement de l'infertilitéProduct Type-BasedInsights
< p> Sur la base du type de produit, le marché des dispositifs et équipements de traitement de l'infertilité est segmenté en pompes d'aspiration d'ovules, dispositifs de séparation de sperme, systèmes d'analyseurs de sperme, systèmes de micromanipulateurs, incubateurs et autres. Le segment des pompes d'aspiration d'ovules détenait la plus grande part du marché dans 2019 et le même segment devrait également enregistrer le TCAC le plus élevé du marché au cours de la période de prévision.
Marché mondial des dispositifs et équipements de traitement de l'infertilité, par type de produit - 2019& 2027
Insights basés sur la procédure
Sur la base de la procédure, le marché des dispositifs et équipements de traitement de l'infertilité est segmenté en technologie de procréation assistée, insémination artificielle et chirurgie de la fertilité. Le segment de l'insémination artificielle détenait la plus grande part du marché en 2019 ; tandis que le segment des technologies de procréation assistée devrait enregistrer le TCAC le plus élevé du marché au cours de la période de prévision.
Insights basés sur l'utilisateur final< /p>
Sur la base de l'utilisateur final, le marché des dispositifs et équipements de traitement de l'infertilité est segmenté en hôpitaux et autres établissements de santé, centres de fertilité et instituts de recherche clinique. Le segment des centres de fertilité détenait la plus grande part du marché en 2019 et est ; en outre, le même segment devrait enregistrer un TCAC sur le marché au cours de la période de prévision.
période 2020-2027.
Insights stratégiques
Stratégies inorganiques telles que les partenariats, les fusions et les acquisitions sont couramment adoptés par les entreprises pour répondre à l'évolution de la demande des clients dans le monde entier, ce qui leur permet également de conserver leur marque. Les acteurs du marché opérant sur le marché des dispositifs et équipements de traitement de l'infertilité ont adopté des stratégies organiques telles que les lancements et les extensions de produits pour étendre leur empreinte et élargir leurs portefeuilles de produits, tout en étant capables de répondre à la demande croissante de produits.
Par type de produit
- Pompes d'aspiration d'ovules
- Dispositifs de séparation de sperme
- Systèmes d'analyse de sperme
- Systèmes de micromanipulateur
- Incubateurs
- Autres
Par procédure
- Technologie de procréation assistée
- Fécondation in vitro
- Injection intracytoplasmique de sperme
- Autres (GIFT, ZIFT, maternité de substitution)
- Insémination artificielle
- Insémination intra-utérine
- Insémination intratubaire
- Insémination intracervicale
- Chirurgie de la fertilité
- Inversion de la ligature des trompes
- Varicocélectomie< /li>
- Laparoscopie
- Autres (laparotomie, myomectomie, reconstruction microchirurgicale, hystéroscopie)
Par utilisateur final
- Cliniques de fertilité
- Hôpitaux et autres établissements de santé
- Instituts de recherche clinique
Par géographie
- Amérique du Nord
- États-Unis
- Canada
- Mexique
- Europe
- France
- Allemagne
- Italie
- Royaume-Uni
- Espagne
- Asie-Pacifique (APAC)
- Chine
- Inde
- Corée du Sud
- Japon
- Australie
- Moyen-Orient et Afrique (MEA)
- Afrique du Sud
- Arabie saoudite
- EAU
- Amérique du Sud et centrale (SCAM)
- Brésil
- Argentine
Profils d'entreprises
- Microptic
- Coopersurgical, Inc,
- Cook Medical LLC
- Dxnow, Eppendorf AG
- AB Scientific Ltd.
- Hamilton Thorne, Inc
- Rocket Medical Plc.
- Invo Bioscience
- Vitrolife
Report Coverage
Revenue forecast, Company Analysis, Industry landscape, Growth factors, and Trends
Segment Covered
This text is related
to segments covered.
Regional Scope
North America, Europe, Asia Pacific, Middle East & Africa, South & Central America
Country Scope
This text is related
to country scope.
Frequently Asked Questions
There are many different infertility treatment options available for patients that can be treated with various devices and equipment. The list of devices and equipment include ovum aspiration pumps, sperm separation devices, sperm analyzer systems, micromanipulator systems, incubators, cryosystems, imaging systems, microscopes, and others.
Many factors are contributing to low fertility rate, thus in coming years, the number of patients seeking infertility treatment will rise. Many companies have developed novel device and procedures for simple, effective and cost effective fertility treatment. Key factors that are contributing to the market growth include increase in the incidence of infertility in both sexes and rising number of fertility clinics & infertility services with government support. However, the high procedural cost of reproductive techniques hinders the market growth.
The cost of infertility treatment varies depending upon the procedure type.For instance, the average procedural cost of one IVF cycle is US$ 12,000 exclusive of the cost of medications; if the couple goes through two or three sequential series. Whereas, in emerging countries, such as India and Australia, it ranges from US$ 814.74 to US$ 1,086.32, inclusive of all medications
The List of Companies - Infertility Treatment Devices and Equipment Market
- MICROPTIC
- CooperSurgical, Inc.
- Cook Medical LLC
- DxNow.
- Eppendorf AG
- AB Scientific Ltd.
- Hamilton Thorne, Inc
- Rocket Medical plc.
- INVO Bioscience
- Vitrolife
The Insight Partners performs research in 4 major stages: Data Collection & Secondary Research, Primary Research, Data Analysis and Data Triangulation & Final Review.
- Data Collection and Secondary Research:
As a market research and consulting firm operating from a decade, we have published and advised several client across the globe. First step for any study will start with an assessment of currently available data and insights from existing reports. Further, historical and current market information is collected from Investor Presentations, Annual Reports, SEC Filings, etc., and other information related to company’s performance and market positioning are gathered from Paid Databases (Factiva, Hoovers, and Reuters) and various other publications available in public domain.
Several associations trade associates, technical forums, institutes, societies and organization are accessed to gain technical as well as market related insights through their publications such as research papers, blogs and press releases related to the studies are referred to get cues about the market. Further, white papers, journals, magazines, and other news articles published in last 3 years are scrutinized and analyzed to understand the current market trends.
- Primary Research:
The primarily interview analysis comprise of data obtained from industry participants interview and answers to survey questions gathered by in-house primary team.
For primary research, interviews are conducted with industry experts/CEOs/Marketing Managers/VPs/Subject Matter Experts from both demand and supply side to get a 360-degree view of the market. The primary team conducts several interviews based on the complexity of the markets to understand the various market trends and dynamics which makes research more credible and precise.
A typical research interview fulfils the following functions:
- Provides first-hand information on the market size, market trends, growth trends, competitive landscape, and outlook
- Validates and strengthens in-house secondary research findings
- Develops the analysis team’s expertise and market understanding
Primary research involves email interactions and telephone interviews for each market, category, segment, and sub-segment across geographies. The participants who typically take part in such a process include, but are not limited to:
- Industry participants: VPs, business development managers, market intelligence managers and national sales managers
- Outside experts: Valuation experts, research analysts and key opinion leaders specializing in the electronics and semiconductor industry.
Below is the breakup of our primary respondents by company, designation, and region:
Once we receive the confirmation from primary research sources or primary respondents, we finalize the base year market estimation and forecast the data as per the macroeconomic and microeconomic factors assessed during data collection.
- Data Analysis:
Once data is validated through both secondary as well as primary respondents, we finalize the market estimations by hypothesis formulation and factor analysis at regional and country level.
- Macro-Economic Factor Analysis:
We analyse macroeconomic indicators such the gross domestic product (GDP), increase in the demand for goods and services across industries, technological advancement, regional economic growth, governmental policies, the influence of COVID-19, PEST analysis, and other aspects. This analysis aids in setting benchmarks for various nations/regions and approximating market splits. Additionally, the general trend of the aforementioned components aid in determining the market's development possibilities.
- Country Level Data:
Various factors that are especially aligned to the country are taken into account to determine the market size for a certain area and country, including the presence of vendors, such as headquarters and offices, the country's GDP, demand patterns, and industry growth. To comprehend the market dynamics for the nation, a number of growth variables, inhibitors, application areas, and current market trends are researched. The aforementioned elements aid in determining the country's overall market's growth potential.
- Company Profile:
The “Table of Contents” is formulated by listing and analyzing more than 25 - 30 companies operating in the market ecosystem across geographies. However, we profile only 10 companies as a standard practice in our syndicate reports. These 10 companies comprise leading, emerging, and regional players. Nonetheless, our analysis is not restricted to the 10 listed companies, we also analyze other companies present in the market to develop a holistic view and understand the prevailing trends. The “Company Profiles” section in the report covers key facts, business description, products & services, financial information, SWOT analysis, and key developments. The financial information presented is extracted from the annual reports and official documents of the publicly listed companies. Upon collecting the information for the sections of respective companies, we verify them via various primary sources and then compile the data in respective company profiles. The company level information helps us in deriving the base number as well as in forecasting the market size.
- Developing Base Number:
Aggregation of sales statistics (2020-2022) and macro-economic factor, and other secondary and primary research insights are utilized to arrive at base number and related market shares for 2022. The data gaps are identified in this step and relevant market data is analyzed, collected from paid primary interviews or databases. On finalizing the base year market size, forecasts are developed on the basis of macro-economic, industry and market growth factors and company level analysis.
- Data Triangulation and Final Review:
The market findings and base year market size calculations are validated from supply as well as demand side. Demand side validations are based on macro-economic factor analysis and benchmarks for respective regions and countries. In case of supply side validations, revenues of major companies are estimated (in case not available) based on industry benchmark, approximate number of employees, product portfolio, and primary interviews revenues are gathered. Further revenue from target product/service segment is assessed to avoid overshooting of market statistics. In case of heavy deviations between supply and demand side values, all thes steps are repeated to achieve synchronization.
We follow an iterative model, wherein we share our research findings with Subject Matter Experts (SME’s) and Key Opinion Leaders (KOLs) until consensus view of the market is not formulated – this model negates any drastic deviation in the opinions of experts. Only validated and universally acceptable research findings are quoted in our reports.
We have important check points that we use to validate our research findings – which we call – data triangulation, where we validate the information, we generate from secondary sources with primary interviews and then we re-validate with our internal data bases and Subject matter experts. This comprehensive model enables us to deliver high quality, reliable data in shortest possible time.
Related Reports
Oct 2020
Colonoscopes Market
Forecast to 2028 - COVID-19 Impact and Global Analysis By Product Type (Fiber Optic Colonoscopy Devices, Video Colonoscopy Devices); Application (Colorectal Cancer, Lynch Syndrome, Ulcerative Colitis, Crohn's Disease, Polyp); End User (Hospitals, Ambulatory Surgery Center, Others), and Geography
Oct 2020
Noninvasive Fat Reduction Market
Size and Forecast (2021 - 2031), Global and Regional Share, Trend, and Growth Opportunity Analysis Report Coverage: By Technology (Cryolipolysis, Laser Lipolysis, Ultrasound, and Others), End User (Hospitals, Dermatology Clinics & Cosmetic Clinics, and Others), and Geography (North America, Europe, Asia Pacific, Middle East & Africa, and South & Central America)
Oct 2020
Medical Ultrasound Flow Meter Market
Size and Forecast (2020 - 2030), Global and Regional Share, Trend, and Growth Opportunity Analysis Report Coverage: By Implementation Type (Clamp-On, Inline, and Others), Technology (Doppler, Transit Time, and Hybrid), Application (Heart and Lung Machines, Extracorporeal Membrane Oxygenation, Perfusion, Organ Transportation Systems, and Others), End User (Hospitals and Clinics, Ambulatory Surgical Centers, Research Laboratories, and Others), and Geography (North America, Europe, Asia Pacific, Middle East & Africa, and South & Central America)
Oct 2020
Rapid Test Kits Market
Size and Forecasts (2020 - 2030), Global and Regional Share, Trend, and Growth Opportunity Analysis Report Coverage: By Type (Rapid Antigen Testing, Rapid Antibody Testing, and Others), Product (Over-the-Counter Rapid Testing Kit and Professional Rapid Testing Kit), Technology (Lateral Flow Assay, Solid Phase, Agglutination, Immunospot Assay, and Cellular Component-Based), Application (Blood Glucose Testing, Infectious Disease Testing, Pregnancy and Fertility, Cardiometabolic Testing, and Others), End User (Hospital and Clinics, Home Care, Diagnostics Centers, and Others), and Geography (North America, Europe, Asia Pacific, Middle East & Africa, and South & Central America)
Oct 2020
Osteoarthritis Therapy Market
Size and Forecasts (2020 - 2030), Global and Regional Share, Trend, and Growth Opportunity Analysis Report Coverage: By Therapy Type [Transcutaneous Electrical Nerve Stimulation (TENS), Occupational Therapy, Physical Therapy, Platelet-Rich Plasma Therapy and Stromal Vascular Fraction, Prolotherapy, and Others], Disease Indication (Knee Osteoarthritis, Spine Osteoarthritis, Foot and Ankle Osteoarthritis, Shoulder Osteoarthritis, Hand Osteoarthritis, and Others), End User (Hospitals & Clinics, Specialty Clinics, Ambulatory Surgical Centers, Homecare, and Others), and Geography (North America, Europe, Asia Pacific, Middle East & Africa, and South & Central America)
Oct 2020
Bariatric Surgeries Market
Size and Forecasts (2020 - 2030), Global and Regional Share, Trends, and Growth Opportunity Analysis Report Coverage: By Type [Adjustable Gastric Bands (AGB), Sleeve Gastrectomy, Gastric Bypass, Biliopancreatic Diversion with Duodenal Switch (BPD-DS), and Others], End User (Hospitals and Ambulatory Surgical Centers), and Geography (North America, Europe, Asia Pacific, Middle East & Africa, and South & Central America)
Oct 2020
Post-Acute Care Market
Size and Forecasts (2020 - 2030), Global and Regional Share, Trends, and Growth Opportunity Analysis Report Coverage: By Service Type (Skilled Nursing Facilities, Inpatient Rehabilitation Facilities, Long-Term Care Hospitals, Home Health Agency, and Others), Age (Elderly, Adult, and Others), Disease Conditions (Amputations, Wound Management, Brain Injury and Spinal Cord Injury, Neurological Disorders, and Others), and Geography
Oct 2020
Lung Cancer Therapy Market
Size and Forecasts (2020 - 2030), Global and Regional Share, Trends, and Growth Opportunity Analysis Report Coverage: By Therapy Type (Noninvasive and Minimally Invasive), Indication (Non-Small Cell Lung Cancer and Small Cell Lung Cancer), End User (Hospitals, Oncology Clinics, Research Centers, and Others), and Geography (North America, Europe, Asia Pacific, South & Central America, and Middle East & Africa)